Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease

Purpose Although dysphonia has been shown to be a common sign of Huntington disease (HD), the extent of phonatory dysfunction in gene positive premanifest HD individuals remains unknown. The aim of the current study was to explore the possible occurrence of phonatory abnormalities in prodromal HD. Method Sustained vowel phonations were acquired from 28 premanifest HD individuals and 28 healthy controls of comparable age. Data were analysed acoustically for measures of several phonatory dimensions including airflow insufficiency, aperiodicity, irregular vibration of vocal folds, signal perturbations, increased noise, vocal tremor and articulation deficiency. A predictive model was built to find the best combination of acoustic features and estimate sensitivity/specificity for differentiation between premanifest HD subjects and controls. The extent of voice deficits according to a specific phonatory dimension was determined using statistical decision making theory. The results were correlated to global motor function, cognitive score, disease burden score and estimated years to disease onset. Results Measures of aperiodicity and increased noise were able to significantly differentiate between premanifest HD individuals and controls (p<0.01). The combination of these aspects of dysphonia led to a sensitivity of 91.5% and specificity of 79.2% to correctly distinguish speakers with premanifest HD from healthy individuals. Some form of disrupted phonatory function was revealed in 68% of our premanifest HD subjects, where 18% had one affected phonatory dimension and 50% showed impairment of two or more dimensions. A relationship between pitch control and cognitive score was also observed (r = −0.50, p = 0.007). Conclusions Phonatory abnormalities are detectable even the in premotor stages of HD. Speech investigation may have the potential to provide functional biomarkers of HD and could be included in future clinical trials and therapeutic interventions.

[1]  Jane S. Paulsen,et al.  Thalamic metabolism and symptom onset in preclinical Huntington's disease. , 2007, Brain : a journal of neurology.

[2]  Nick C Fox,et al.  Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.

[3]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[4]  Max A. Little,et al.  Novel Speech Signal Processing Algorithms for High-Accuracy Classification of Parkinson's Disease , 2012, IEEE Transactions on Biomedical Engineering.

[5]  Jane S. Paulsen,et al.  Neurocognitive signs in prodromal Huntington disease. , 2011, Neuropsychology.

[6]  E. W. Lovrien,et al.  Oral motor dysfunction in individuals at risk of Huntington disease. , 1990, American journal of medical genetics.

[7]  J A Molina,et al.  Acoustic voice analysis in patients with essential tremor. , 1998, Journal of voice : official journal of the Voice Foundation.

[8]  C. Ludlow,et al.  Manual of Nerve Conduction Velocity and Clinical Neurophysiology, 3rd Ed. , 1994, Neurology.

[9]  Paul Boersma,et al.  Praat, a system for doing phonetics by computer , 2002 .

[10]  Ira Shoulson,et al.  Huntington's disease in venezuela: 7 years of follow‐up on symptomatic and asymptomatic individuals , 1990, Movement disorders : official journal of the Movement Disorder Society.

[11]  Hana Brožová,et al.  A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse , 2014, Journal of Neural Transmission.

[12]  Chris Frost,et al.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data , 2013, The Lancet Neurology.

[13]  H. Przuntek,et al.  Assessment of complex movements reflects dysfunction in Huntington’s disease , 2003, Journal of Neurology.

[14]  Paul W Goldberg,et al.  A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. , 1994, The New England journal of medicine.

[15]  Evžen Růžička,et al.  Characteristics and occurrence of speech impairment in Huntington’s disease: possible influence of antipsychotic medication , 2014, Journal of Neural Transmission.

[16]  Sang Joon Lee,et al.  Controlled cellular uptake and drug efficacy of nanotherapeutics , 2013, Scientific Reports.

[17]  Kyung K. Peck,et al.  Event-related functional MRI investigation of vocal pitch variation , 2009, NeuroImage.

[18]  Katja Laakso,et al.  Speech Disorders in Mild and Moderate Huntington Disease: Results of Dysarthria Assessments of 19 Individuals , 2003 .

[19]  Chris Frost,et al.  Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis , 2011, The Lancet Neurology.

[20]  Roman Cmejla,et al.  Automatic Evaluation of Articulatory Disorders in Parkinson’s Disease , 2014, IEEE/ACM Transactions on Audio, Speech, and Language Processing.

[21]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.

[22]  E. Siemers,et al.  Subtle changes among presymptomatic carriers of the Huntington's disease gene , 2000, Journal of neurology, neurosurgery, and psychiatry.

[23]  B. Leavitt,et al.  Development of biomarkers for Huntington's disease , 2011, The Lancet Neurology.

[24]  Jane S. Paulsen,et al.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length , 2004, Clinical genetics.

[25]  C. Beste,et al.  A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data , 2013, Scientific Reports.

[26]  Carsten Saft,et al.  Assessment of simple movements reflects impairment in Huntington's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[27]  L. Ramig,et al.  Acoustic Analyses of Phonation in Patients with Huntington's Disease , 1986, The Annals of otology, rhinology, and laryngology.

[28]  I. Cobeta,et al.  Acoustic analysis of voice in Huntington's disease patients. , 2011, Journal of voice : official journal of the Voice Foundation.

[29]  Adam P. Vogel,et al.  Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset? , 2012, Neuropsychologia.

[30]  S. Skodda,et al.  Impaired motor speech performance in Huntington’s disease , 2014, Journal of Neural Transmission.

[31]  Max A. Little,et al.  Exploiting Nonlinear Recurrence and Fractal Scaling Properties for Voice Disorder Detection , 2007, Biomedical engineering online.

[32]  Veronika Majerová,et al.  Objective Acoustic Quantification of Phonatory Dysfunction in Huntington's Disease , 2013, PloS one.